Our mission is to harness the power of nature’s defense mechanisms to develop a revolutionary drug delivery platform built on glycosylated mucin nanoparticles. This advanced, scalable, and sustainable technology redefines pharmaceutical development by unlocking API repurposing and maximizing targeting and mucoadhesivity, delivering unmatched results in therapeutic solutions.
Our vision is to be the strategic partner of choice for the pharmaceutical market, offering versatile, high-impact solutions in infectious diseases, oncology, and other mucosal health applications. Committed to relentless innovation, we empower our partners to deliver breakthrough therapies that transform healthcare and improve patient outcomes.
Excellence through diverse knowledge, synergy & external influence
Robust Scientific Foundation from Academia & Industry combined with market-driven leadership
Platform Development
FUB Postdoctoral Researcher, UniTO PhD in Pharmaceutical & Biomolecular Science
Coordinator
IQVIA RWE Consultant
MIT Visiting Researcher, Harvard, Fulbright, Polimi
Mastery & Multidisciplinarity Across Scientific Domains